Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.

167 indexed citations

Abstract

loading...

About

This paper, published in 2022, received 167 indexed citations. Written by Mark S. Butler, Valeria Gigante, Hatim Sati, Sarah Paulin, John Rex, Prabhavathi Fernandes, César A. Arias, Mical Paul, Guy Thwaites and Lloyd G. Czaplewski covering the research area of Infectious Diseases, Applied Microbiology and Biotechnology and Molecular Medicine. It is primarily cited by scholars working on Molecular Medicine (85 citations), Molecular Biology (66 citations) and Pharmacology (33 citations). Published in Oxford University Research Archive (ORA) (University of Oxford).

In The Last Decade

doi.org/w12047718 →

Countries where authors are citing Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.

Specialization
Citations

This map shows the geographic impact of Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. more than expected).

Fields of papers citing Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w12047718.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026